The putative rate-limiting step for the biosynthesis of norepinephrine is the hydroxylation of tyrosine to dopa catalyzed by the enzyme tyrosine hydroxylase. 4 We observed an increase in the activity of this enzyme in the myopathic hamster heart during cardiac decompensation. 5 This increase in tyrosine hydroxylase correlated well with the increase in cardiac sympathetic tone. However, cardiac norepinephrine synthesis remained relatively constant, failing to reflect these increases. It is possible that, despite the measured increase in tyrosine hydroxylase activity in vitro, changes in precursor, product, and cofactor relationships obtaining in vivo obviated an increase in in vivo synthesis. It also was possible that the hydroxylation of tyrosine was no longer the rate-limiting step for norepinephrine synthesis in the failing myopathic hamster heart and that the hydroxylation of dopamine became rate-limiting. If the latter were true, we would expect to find an accumulation of cardiac dopamine accompanying the decline of norepinephrine stores. To evaluate this latter hypothesis, we examined the cardiac contents of dopamine and norepinephrine in cardiomyopathic and control hamsters at rest and during alterations in cardiac sympathetic tone.
Methods
Both norepinephrine and dopamine were measured in the hearts of cardiomyopathic hamsters (Bio 53.58; TELACO) and of their age-and sex-matched controls (RB) at representative stages in the course of the cardiomyopathy. The hamsters were killed by decapitation. Their hearts and thigh muscles were removed and rinsed; the ventricles were dissected free of the atria and great vessels. The tissues immediately were frozen on dry ice. The muscle specimens and ventricles were weighed, homogenized with a Polytron homogenizer in 30 volumes of iced 0.1 N perchloric acid, and centrifuged at 30,000 g for 30 minutes. The supernatant fluids were stored at -75°C before analysis.
Norepinephrine and dopamine were assayed by a micromodification of the radioenzymatic method of Coyle and Henry 6 exactly as described by Palkovits et al. 7 In this assay, dopamine and norepinephrine in the tissue supernatant fluids were converted to their O-methylated analogues in the presence of catechol-0-methyl transferase and S-adenosyl-methionine( 3 H-methyl) (specific activity, 11.6 Ci/mmole; New England Nuclear). The labeled normetanephrine and 3-methoxytyramine were extracted and the former was converted to vanillin( 3 H-methyl) by metaperiodate cleavage. The methoxytyramine( 3 H-methyl) and vanillin( 3 H-methyl) were separated by solvent extraction and counted in a liquid scintillation counter.
To calculate norepinephrine turnover in skeletal muscle, a-methyl-para-tyrosine (250 mg/kg), an inhibitor of norepinephrine synthesis, was administered by intraperitoneal injection at intervals of 3 hours. Three groups of five 240-to 270-day old hamsters from each of the myopathic and control strains were killed at 0, 3, and 6 hours. The turnover rate constant was calculated from the rate of decline of the logarithm of the muscle norepinephrine concentration (regression coefficient). Analysis of variance was used for calculating the standard error of the regression coefficient and the significance of the regression coefficients.
Chlorisondamine (Ecolid chloride), a ganglionic blocker which does not enter the central nervous system, was used to inhibit peripheral sympathetic activity in one of our studies; 10 mg/kg was given to the treated hamsters by intraperitoneal injection every 6 hours for 24 hours. Untreated hamsters received the 0.9% saline vehicle. The hamsters were killed at 24 hours and the hearts were taken for catecholamine analysis.
For some experiments, hamsters were stressed by immobilization 2 by taping their limbs to a board. Their heads were free to move and they were allowed access to water, but not food. The animals were left undisturbed and not in pain. At 24 hours, the hamsters were decapitated while still immobilized. The experiment adhered to the rules for the humane treatment of animals as set by the University of Toronto.
Results
The cardiomyopathy of the Bio 53.58 hamster, like that of other cardiomyopathic hamster strains, may be divided into several pathophysiological stages. 1 At 30-40 days of age, areas of focal myolysis and cellular infiltrates appear in the hearts of myopathic animals. Although these lesions appear to "heal" in the following 2 months, the myocardial mass gradually increases and the heart dilates. The terminal stages of the heart disease in the myopathic hamsters used in these experiments occurred at 240-270 days of age. Preliminary experiments demonstrated that cardiac sympathetic tone and tyrosine hydroxylase activity greatly increased during cardiac decompensation in a manner similar to that previously reported for the Bio 14.6 strain. 2 -5 Dopamine levels were approximately 8-9% of norepinephrine levels in the hearts of hamsters 30-40 days old, and 10-13% of norepinephrine levels in those 140-160 days old (Table 1 ). There was no difference in cardiac catecholamine stores between normal and myopathic hamsters during these stages. We found a striking change in cardiac norepinephrine and dopamine levels in 240-to 270-day-oId myopathic animals ( Table 1 ). The concentration (and content) of cardiac norepinephrine was a fraction of that found in the controls. Cardiac dopamine, on the other hand, was increased several-fold in an almost stoichiometric fashion. It was possible that our observations reflected a neurohumoral abnormality found generally in hamster dystrophic muscle. Therefore, we measured norepinephrine and dopamine in the.hindleg muscles of failing dystrophic and control hamsters ( Table 2 ). We found no differences in either norepinephrine concentration or turnover. Dopamine concentration in myopathic muscles was reduced. We previously had shown that cardiac norepinephrine stores in failing hamsters of the 14.6 strain could be restored following peripheral ganglionic blockade by chlorisondamine. 2 Chlorisondamine administration to control hamsters had no effect on either the distribution or the steady state levels of cardiac catecholamines (Fig. 1 ). Prior to chlorisondamine treatment, the content of cardiac norepinephrine and dopamine in terminally ill myopathic hamsters was approximately 12% and 550% of control values, respectively. Dopamine content was 7 times that of norepinephrine in myopathic hearts. Both the dramatic decrease in norepinephrine and increase in dopamine in failing myopathic hearts were completely abolished by peripheral ganglionic blockade (Fig. 1 ). It appeared that alterations of sympathetic tone were capable of affecting catecholamine distribution within the failing heart. We wished to determine whether these observations held true for a relatively acute increase in sympathetic tone in normal hearts. We stressed control hamsters by immobilization 2 for 24 hours. Cardiac norepinephrine levels fell (Fig. 2) ; cardiac dopamine, however, showed a significant and almost stoichiometric rise.
Discussion
Congestive heart failure in the cardiomyopathic hamster is accompanied by an increase in cardiac sympathetic tone and a decrease in cardiac norepinephrine stores. 2 We have demonstrated that an accumulation of dopamine accompanies the decline of norepinephrine in the decompensating hamster heart. The abnormal contents of both norepinephrine and dopamine could be restored completely to normal values by peripheral ganglionic blockade. Thus, alterations in sympathetic tone dramatically affected catecholamine distribution within the sympathetic nerve endings of the failing heart.
A substance with catecholamine-like histofluorescent properties has been described as accumulating in the skeletal muscle fibers of patients with sex-linked pseudohypertrophic muscular dystrophy. 8 The noradrenergic innervation of the dystrophic hamster heart has been examined by the formaldehyde fluorescent histochemical technique of Falck and Hillarp. 3 Definite alterations in both the configuration and intensity of catecholamine fluorescence were seen in the nerve terminals of dystrophic hearts, but there was apparently no accumulation of intrafibrillar monoamines. Gordon and Dowben 9 found a decrease in cardiac norepinephrine and an increase in skeletal muscle norepinephrine and epinephrine in the dystrophic mouse. Although they did not measure tissue dopamine, they did note elevations in the urinary excretion of dopamine as well as of norepinephrine and epinephrine. A significant increase in the urinary excretion of norepinephrine and epinephrine by myopathic hamsters was found by Kabara et al. 10 However, these workers failed to find a change in urinary dopamine. We found no increase in either the norepinephrine turnover rate or the dopamine concentration of dystrophic hamster skeletal muscle. Thus the increase in both norepinephrine turnover and dopamine stores of the heart was not a manifestation of a neurohumoral abnormality found generally in the dystrophic striated muscles of the hamster. The rates of individual steps in a sequence of enzymatic reactions are determined by the steady state concentration of each intermediate in the sequence as well as the kinetic characteristics and concentration of each enzyme. The rate of norepinephrine synthesis in the decompensating hamster heart remains relatively constant in spite of an increase in both cardiac sympathetic tone and tyrosine hydroxylase activity. In this setting, the accumulation of dopamine in the presence of a decrease in norepinephrine is compatible with a shift in the rate-limiting step for norepinephrine synthesis from the hydroxylation of tyrosine to the hydroxylation of dopamine.
The conversion of dopamine to norepinephrine is complex. Dopamine-/3-hydroxylase, like tyrosine hydroxylase, may be induced by an increase in sympathetic tone." Dopamine-/3-hydroxylase, however, is located largely within the noradrenergic nerve granules; thus, in response to sympathetic stimulation, the enzyme is lost from the nerve terminal by exocytosis. 12 -13 An imbalance between dopamine-/3-hydroxylase production and loss could cause enzyme activity to fall 13 to the point of being inadequate to meet heightened demands for norepinephrine synthesis. Furthermore, as dopamine-/3-hydroxylase is sequestered within the noradrenergic nerve granule, dopamine must be transported across the vesicular membrane prior to hydroxylation. An imbalance between the production and loss of nerve granules could theoretically reduce the number of dopamine transport and/or norepinephrine storage sites and thus limit dopamine conversion. The inherent kinetic characteristics of the dopamine transport process itself could also be limiting. Finally, dopamine-/3hydroxylase appears to be regulated both by cofactors 14 and endogenous inhibitors. 15 It is possible that the relationship of the enzyme to these modifiers could change in response to alterations in sympathetic nerve traffic.
These observations also appear to hold for relatively acute increases in sympathetic tone in normal hamsters. The severe stress imposed on control hamsters by prolonged immobilization resulted in a decrease in cardiac norepinephrine and an increase in cardiac dopamine similar to that found in hamster heart failure. Other studies also support the possible general applicability of our observations. An increase in adrenal medullary dopamine has been described following neurogenic stimulation of the adrenal. 1 " In addition, Snider et al. 17 showed that electrical stimulation of the sympathetic nerves supplying the submaxillary gland of the rat leads to both a decrease in norepinephrine and an increase in dopamine in the stimulated gland. Their results indicated that this dopamine was bound largely to granules in the nerve terminal.
These results are particularly interesting in the light of recent studies examining negative feedback mechanisms for neurotransmitter release. Dopamine appears to be a potent inhibitor of norepinephrine release from peripheral sympathetic nerve endings. 18 " 20 There is some evidence that this inhibition may be mediated by presynaptic dopaminergic receptors. 18 " 20 If dopamine, in response to an increase in sympathetic tone, were to accumulate in a functionally releasable pool, one might postulate that it acts to inhibit excessive norepinephrine release and thus conserve neurotransmitter stores.
Our experiments provide no indication of whether cardiac dopamine in the stressed or failing hamster is largely in a functionally releasable pool or indeed is intraor extravesicular. Further experiments examining the conversion of tyrosine into dopamine and dopamine into norepinephrine under conditions of increased sympathetic tone also are clearly needed. We can conclude, however, that the increase in cardiac sympathetic tone in the late stages of hamster cardiomyopathy appears to lead to a shift in the rate-limiting step for cardiac norepinephrine synthesis from the hydroxylation of tyrosine to the hydroxylation of dopamine. There is evidence that this shift, which results in an accumulation of dopamine in the noradrenergic nerve terminals of the heart, is a general manifestation of augmented sympathetic nerve traffic rather than a peculiarity of hamster cardiomyopathy.
